Skip to main content
Equibles
DNA logo

DNA · Ginkgo Bioworks Holdings, Inc. · Investor Relations

Track DNA — free

Use DNA with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research DNA.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$12.35 -0.15 (-1.20%) At close · Oct 2
Russell 2000 member Rebalance outlook locked
Market Cap
$844.45M
Shares
67.34M
Volume · Oct 2 2.04M Avg daily vol (3M) 1.4M

Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.

Recent news

Date Headline
2026-09-16 Ginkgo Datapoints Announces Partnership with TuneLab to Close the Gap between AI Models and Lab Data
2026-09-15 Ginkgo Bioworks to Build an Autonomous Lab at Novo’s New U.S. R&D Site in Waltham
2026-09-10 Ginkgo Bioworks Joins ARPA-H GIVE Program to Build Autonomous Manufacturing System for Individualized RNA Medicines
2026-08-05 Ginkgo Bioworks Reports Second Quarter 2026 Results, Wins Government Contracts to Build Autonomous Labs at MIT, Caltech, Northwestern, and University of Maryland
2026-08-05 Ginkgo Bioworks Expands Autonomous Lab Network to Caltech, MIT, Maryland and Northwestern
2026-08-03 Ginkgo Bioworks and Acies Bio Partner to Expand Global Access to High-Performance Aspergillus niger Strains for Protein Production
2026-07-30 Ginkgo Bioworks Announces Date of Second Quarter 2026 Results Presentation
2026-05-26 Ginkgo Datapoints, Tangible Scientific, and Inductive Bio Launch ADME-One™: a High-Throughput ADME Platform That Brings Pharmacokinetic Projection Earlier in Drug Discovery
2026-05-07 Ginkgo Bioworks Reports First Quarter 2026 Financial Results, Completes Divestiture of Biosecurity and Continues to Scale Autonomous Lab
2026-04-30 Ginkgo Bioworks Announces Date of First Quarter 2026 Results Presentation
2026-03-02 Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
2026-02-26 Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
2026-02-19 Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation
2026-02-18 Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
2026-02-05 Ginkgo Bioworks' Autonomous Laboratory Driven by OpenAI's GPT-5 Achieves 40% Improvement Over State-of-the-Art Scientific Benchmark
2026-01-13 Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference
2025-12-22 Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach

Past events

Date Event Type
2026-08-05 Q2 FY2026 Earnings conference call (announced in 8-K) Earnings call
2026-05-07 Earnings conference call (announced in 8-K) Earnings call
2026-02-26 Ginkgo Bioworks Announces Date of Fourth Quarter and Full Year 2025 Results Presentation Earnings call
2026-01-15 Ginkgo Bioworks Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference Conference
2025-11-06 Ginkgo Bioworks Q3 2025 Results Results publication
2025-08-07 Ginkgo Bioworks Q2 2025 Results Results publication
2025-05-06 Ginkgo Bioworks Q1 2025 Results Results publication
2025-02-25 Ginkgo Bioworks Q4 and Full Year 2024 Update & Business Review Event
2025-01-16 JP Morgan Annual Healthcare Conference Conference
2024-11-12 Ginkgo Bioworks Q3 2024 Results Results publication
2024-09-06 Morgan Stanley 22nd Annual Global Healthcare Conference Conference
2024-08-08 Ginkgo Bioworks Q2 2024 Results Results publication
2024-05-30 Leerink Partners Healthcare Crossroads Conference Conference
2024-05-22 TD Cowen 2nd Annual Sustainability Week Event
2024-05-09 Ginkgo Bioworks Q1 2024 Results Results publication
2024-04-11 Ginkgo Ferment 2024 Event
2024-03-04 TD Cowen 44th Annual Health Care Conference Conference
2024-02-29 Q4 & YE 2023 Results Results publication
2024-01-10 JP Morgan Annual Healthcare Conference Conference
2023-11-08 Ginkgo Bioworks Q3 2023 Results Results publication
2023-10-03 October 2023 Investor Day Presentation
2023-09-13 Morgan Stanley 21st Annual Global Healthcare Conference Conference
2023-08-15 UBS MedTech, Tools and Genomics Summit Event
2023-08-09 Ginkgo Bioworks Q2 2023 Results Results publication
2023-06-12 Goldman Sachs Global Healthcare Conference Conference

Source: https://investors.ginkgobioworks.com/

Key facts CIK 1830214 CUSIP 37611X209 13F (30d) 2 filings 2 filers Visit website Investor relations